Konstantinos Porpodis Selected Research

Roflumilast

1/2015

Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konstantinos Porpodis Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 01/2012
16	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2012
15	Asthma (Bronchial Asthma) 07/2023 - 08/2009
7	Neoplasm Metastasis (Metastasis) 03/2024 - 08/2014
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 01/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 12/2012
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2013
4	Inflammation (Inflammations) 01/2023 - 01/2013
3	Pulmonary Hypertension 01/2024 - 01/2011
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 01/2015
3	Disease Progression 01/2019 - 01/2013
2	COVID-19 01/2023 - 10/2022
2	Carcinogenesis 01/2022 - 01/2020
2	Dyspnea (Shortness of Breath) 05/2019 - 06/2017
2	Adenocarcinoma 01/2017 - 02/2015
2	Carcinoid Tumor (Carcinoid) 01/2016 - 01/2012
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2023
1	Peritoneal Neoplasms 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2021
1	Obstructive Sleep Apnea 12/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Persistent Infection 01/2020
1	Bursitis (Adhesive Capsulitis) 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Weight Loss (Weight Reduction) 05/2016
1	Postoperative Pain 01/2016
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2015

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2013
3	Monoclonal AntibodiesIBA 01/2023 - 01/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 01/2015
3	Methacholine Chloride (Methacholine)FDA Link 01/2021 - 08/2009
3	PlatinumIBA 01/2017 - 01/2013
2	B7-H1 AntigenIBA 03/2024 - 01/2023
2	Omalizumab (Xolair)FDA Link 01/2022 - 01/2021
2	mepolizumabIBA 01/2022 - 01/2020
2	Ki-67 Antigen (Ki 67 Antigen)IBA 01/2022 - 04/2020
2	SteroidsIBA 01/2021 - 06/2017
2	Carboplatin (JM8)FDA LinkGeneric 02/2020 - 01/2013
2	AsbestosIBA 01/2020 - 01/2012
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019 - 01/2015
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2019 - 01/2015
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 01/2014
2	AerosolsIBA 01/2014 - 01/2012
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014 - 01/2013
1	LigandsIBA 03/2024
1	AntigensIBA 03/2024
1	ACE-011IBA 01/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2024
1	Iloprost (Ventavis)FDA Link 01/2024
1	NivolumabIBA 02/2023
1	EnzymesIBA 01/2023
1	Formoterol Fumarate (Oxis)FDA Link 01/2023
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2023
1	Beclomethasone (Beclometasone)FDA Link 01/2023
1	Nanoparticle Drug Delivery SystemIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	regorafenibIBA 01/2022
1	Circular RNAIBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	Long Noncoding RNAIBA 07/2020
1	Sunitinib (Sutent)FDA Link 04/2020
1	norvalineIBA 04/2020
1	Transcription Factors (Transcription Factor)IBA 02/2020
1	Pyruvic Acid (Pyruvate)IBA 02/2020
1	Interleukin-5 (Interleukin 5)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	GoldIBA 05/2019
1	Insulin-Like PeptidesIBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	technetium Tc 99m hydrazinonicotinyl-Tyr(3)-octreotideIBA 01/2019
1	Chromogranin AIBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	CytokinesIBA 01/2019
1	Bronchodilator Agents (Bronchodilators)IBA 06/2017
1	Mannitol (Osmitrol)FDA LinkGeneric 06/2017
1	Phosphodiesterase InhibitorsIBA 01/2017
1	AfatinibIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Drug CombinationsIBA 01/2017
1	AntibodiesIBA 01/2016
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2015

Therapy/Procedure

21	Therapeutics 07/2023 - 01/2012
15	Drug Therapy (Chemotherapy) 01/2023 - 01/2012
8	Immunotherapy 03/2024 - 01/2013
3	Radiotherapy 01/2020 - 08/2014
2	Nebulizers and Vaporizers (Inhaler) 07/2023 - 01/2023
2	Aftercare (After-Treatment) 01/2023 - 01/2011
2	Conservative Treatment 03/2014 - 01/2012
1	Radiofrequency Ablation 01/2023
1	Artificial Respiration (Mechanical Ventilation) 10/2022
1	Photothermal Therapy 01/2022
1	Nanospheres 01/2022
1	Intraperitoneal Injections 01/2022
1	Biological Therapy 01/2022
1	Cytoreduction Surgical Procedures 01/2022
1	Continuous Positive Airway Pressure 12/2021
1	Thoracotomy 01/2016
1	Length of Stay 01/2016